Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardioangiologica 2016 August;64(4) > Minerva Cardioangiologica 2016 August;64(4):442-61

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as
Share

 

REVIEWS  NEW BIORESORBABLE TECHNOLOGY IN INTERVENTIONAL CARDIOLOGY 

Minerva Cardioangiologica 2016 August;64(4):442-61

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Imaging and functional assessment of bioresorbable scaffolds

Michele PIGHI, Jean-François TANGUAY, Philippe L. L’ ALLIER

Department of Medicine, Montreal Heart Institute, Université de Montréal, Montreal, Canada


PDF


Bioresorbable vascular scaffolds (BRS) are novel devices designed to provide transient vessel support to drug-delivery capability without the potential long-term limitations of metallic drug-eluting stents. The technology, heralded as the latest revolution in the field of percutaneous coronary intervention, could overcome many of the long-term safety concerns associated with metallic stents and possibly even convey a further clinical benefit. However, despite its theoretical advantages, the safety and efficacy of the first generation BRS remain unclear in all-comer patient populations. Invasive imaging modalities and methodologies were developed to guide BRS implantation and monitor the interaction between the scaffold and the vessel at long-term follow-up. These tools are helpful to avoid some of the pitfalls associated with BRS implantation and may improve the clinical outcome of these devices. The present review aims to report the most recent data regarding multi-imaging modalities as guidance and follow-up of coronary interventions involving the use of BRS.

top of page